Metropolitan Life Insurance Company (MetLife)’s Nkarta NKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,650
Closed -$17.8K 1379
2024
Q1
$17.8K Buy
+1,650
New +$17.2K ﹤0.01% 1921
2023
Q3
Sell
-1,827
Closed -$4K 2431
2023
Q2
$4K Buy
1,827
+1,619
+778% +$7.12K ﹤0.01% 2451
2023
Q1
$738 Sell
208
-1,778
-90% -$8.43K ﹤0.01% 2306
2022
Q4
$11.9K Hold
1,986
﹤0.01% 2228
2022
Q3
$26.1K Hold
1,986
﹤0.01% 1874
2022
Q2
$24.5K Buy
+1,986
New +$26.1K ﹤0.01% 1942
2021
Q4
Sell
-3,933
Closed -$109K 2815
2021
Q3
$109K Sell
3,933
-2,370
-38% -$75.1K ﹤0.01% 2474
2021
Q2
$200K Buy
6,303
+491
+8% +$14.1K ﹤0.01% 2144
2021
Q1
$191K Buy
5,812
+839
+17% +$40.1K ﹤0.01% 2048
2020
Q4
$306K Hold
4,973
﹤0.01% 1668
2020
Q3
$149K Buy
+4,973
New +$147K ﹤0.01% 1960

Other funds holding NKTX

Metropolitan Life Insurance Company (MetLife)'s NKTX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Nkarta (NKTX) in Q2 2024, closing a stake of 1,650 shares — an estimated $17.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NKTX in Q3 2020 and held it in 11 quarters. The position peaked at $306K in Q4 2020. 112 funds tracked by Wall St. Rank hold NKTX as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Nkarta position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,650 Nkarta shares in Q2 2024, an estimated $17.8K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Nkarta in Q3 2020 and held it in 11 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Nkarta position peaked at $306K in Q4 2020.
  • 112 funds tracked by Wall St. Rank held Nkarta as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.